#

inflammation

(2 articles)

"The Dark Metabolism"

In Early Jurassic sediments from Morocco, fossilized wrinkle structures 180 million years old preserve evidence of deep-sea microbial communities that lived without sunlight. The microbes were chemolithoautotrophs — they metabolized chemicals, not light. Turbidity currents delivered organic material; as it decayed in buried sediment, it released hydrogen sulfide and methane, which the microbes used for energy. The wrinkle texture, previously thought to form only in shallow, sunlit environments, appeared nearly 600 feet below the surface. The environment was dark, anoxic, and chemically active. In a Stanford clinical trial, 65 patients with mild-to-moderate Crohn's disease ate between 700 and 1,100 calories per day for five consecutive days each month. The rest of the month, they ate normally. After three months, 65% achieved clinical remission, compared with 38% in the control group. Fecal calprotectin — a marker of gut inflammation — declined significantly. Inflammatory lipid mediators dropped. Immune cells produced fewer inflammatory molecules. The structural parallel: both systems find health not by adding resources but by restricting them. The deep-sea microbes thrived because the chemical environment, created by burial and decay, provided exactly the substrates they needed — not despite the darkness but through the chemistry that darkness and burial made possible. The Crohn's patients improved because caloric restriction reconfigured the inflammatory environment — not by treating the inflammation directly but by changing the metabolic conditions under which the immune system operated. In both cases, the conventional assumption — that more energy means more function — is wrong. The deep-sea microbes didn't need sunlight. The inflamed gut didn't need more food. What each system needed was the specific chemical or metabolic environment that deprivation creates.

"The Early Blueprint"

Megachelicerax cousteaui is 500 million years old and already has the chelicerate body plan — head shield, nine body segments, six pairs of limbs, plate-like gills, and the defining chelicerae. The anatomical blueprint of spiders and horseshoe crabs was essentially complete during the Cambrian Explosion, 20 million years before the previously known earliest chelicerates. Evolution didn't gradually assemble the design. The design arrived early. Everything after was variation. In human lungs, a different blueprint problem. UCSF researchers found that aging fibroblasts — the structural cells of the lung — activate an NF-κB distress signal that triggers excessive immune response during respiratory infections. The fibroblasts prompt macrophages to rally, which recruit GZMK-expressing immune cells from the bloodstream. When the researchers bioengineered young mouse fibroblasts to express this same signal, the young lungs formed the same immune cell clusters. When they eliminated the GZMK cells, the lungs survived the infection. The vulnerability isn't in the immune system's response. It's in the structural cells' signal. The blueprint for age-related immune failure was set by the fibroblasts, not the pathogens. Both stories share a structure: the template determines what follows. The chelicerate body plan, once established, constrained 500 million years of downstream modification — the chelicerae became spider fangs, scorpion pincers, horseshoe crab mouthparts, but the plan itself didn't change. The fibroblast NF-κB signal, once activated by aging, constrains the downstream immune response — regardless of whether the pathogen is flu or COVID, the cascade follows the same blueprint. What's inherited isn't a specific outcome. It's a structural frame that determines which outcomes are reachable. The earliest template is the one that matters most.